- Kimberly-Clark’s adjusted earnings per share (EPS) for the second quarter exceeded expectations, coming in at $1.92 compared to the estimate of $1.68.
- Net sales for the quarter were reported at $4.16 billion, representing a decrease of 1.6% year-over-year.
- In North America, net sales totaled $2.73 billion, down 1.9% from the same period last year.
- The company’s organic sales increased by 3.9% during this period.
- There was a reported 5% increase in net sales volume.
- International Personal Care net sales saw a slight increase of 0.4% year-over-year, reaching $1.43 billion.
Kimberly Clark on Smartkarma
Kimberly-Clark’s analyst coverage on Smartkarma highlights insights from Baptista Research, with a bullish sentiment towards the company. The report titled “Kimberly-Clark: Consumer-Centric Product Strategy to Reinforce Brand Trust & Enhance The Customer Base!” delves into the company’s recent earnings performance in the first quarter of 2025 and its strategic outlook. Despite a softer top line compared to expectations, Kimberly-Clark’s results were in line with full-year plan projections. The company continues to prioritize its Powering Care strategy, focusing on innovation across a range of consumer offerings.
A look at Kimberly Clark Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Kimberly-Clark Corporation, a global health and hygiene company known for its wide range of consumer products, has been assigned Smartkarma Smart Scores indicating its long-term outlook. With solid scores in Dividend and Growth factors, the company shows promising signs of stability and potential for expansion.
While Kimberly-Clark scored lower in Value and Resilience factors, its steady Momentum score suggests a moderate growth trajectory. As a leading manufacturer of essential products like diapers, tissues, and surgical gowns sold worldwide, Kimberly-Clark’s position in the market seems set to benefit from its strong dividend yield and growth prospects in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
